PYPD PolyPid Ltd.
PolyPid Ltd. (PYPD) is expected to report earnings on November 11, 2026, before the market open. The consensus earnings estimate is a loss of $0.41 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.3% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About PolyPid Ltd.
PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.
Sector
Healthcare
Industry
Drug Manufacturers/Other